# Pharmacokinetic Interaction Trial of Clofutriben With Midazolam and Prednisolone

> **NCT07226635** · PHASE1 · COMPLETED · sponsor: **Sparrow Pharmaceuticals** · enrollment: 16 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** midazolam
- **DRUG:** clofutriben once daily for 16 days
- **DRUG:** 2 single oral doses of prednisolone

## Key facts

- **NCT ID:** NCT07226635
- **Lead sponsor:** Sparrow Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-03
- **Primary completion:** 2025-12-16
- **Final completion:** 2025-12-16
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07226635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07226635, "Pharmacokinetic Interaction Trial of Clofutriben With Midazolam and Prednisolone". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT07226635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*